Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-09

Clinical Trial Update: Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification [Phase 4]

View source ↗

Summary

Phase 4 trial update on subconjunctival atropine and intracameral epinephrine for pupil dilation during cataract surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atropine (atropine)
  • EPINEPHRINE (EPINEPHRINE)

Snippet

Sponsor: Dar El Oyoun Hospital | Conditions: Cataract, Mydriasis | Phase 4 | Status: UNKNOWN